These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1776137)

  • 21. The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity.
    Walenga JM; Bara L; Petitou M; Samama M; Fareed J; Choay J
    Thromb Res; 1988 Jul; 51(1):23-33. PubMed ID: 3166242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes.
    Gustafsson D; Antonsson T; Bylund R; Eriksson U; Gyzander E; Nilsson I; Elg M; Mattsson C; Deinum J; Pehrsson S; Karlsson O; Nilsson A; Sörensen H
    Thromb Haemost; 1998 Jan; 79(1):110-8. PubMed ID: 9459334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications.
    Plummer JS; Berryman KA; Cai C; Cody WL; DiMaio J; Doherty AM; Edmunds JJ; He JX; Holland DR; Levesque S; Kent DR; Narasimhan LS; Rubin JR; Rapundalo ST; Siddiqui MA; Susser AJ; St-Denis Y; Winocour PD
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3409-14. PubMed ID: 9873743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerastocytin, a new thrombin-like platelet activator from the venom of the Tunisian viper Cerastes cerastes.
    Marrakchi N; Zingali RB; Karoui H; Bon C; el Ayeb M
    Biochim Biophys Acta; 1995 May; 1244(1):147-56. PubMed ID: 7766651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effects of various anticoagulants on blood coagulation: with special reference to false positive lupus anticoagulants].
    Onda H; Watanabe H
    Rinsho Byori; 1989 Dec; 37(12):1385-91. PubMed ID: 2515325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of serine proteases of the blood coagulation system by squash family protease inhibitors.
    Hayashi K; Takehisa T; Hamato N; Takano R; Hara S; Miyata T; Kato H
    J Biochem; 1994 Nov; 116(5):1013-18. PubMed ID: 7896727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human umbilical vein smooth muscle cells as a model to study thrombin generation and function: effect of thrombin inhibitors.
    Catalioto RM; Cucchi P; Renzetti AR; Criscuoli M; Subissi A
    Thromb Haemost; 1996 Oct; 76(4):603-9. PubMed ID: 8903003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
    Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in rats.
    Sato K; Taniuchi Y; Kawasaki T; Hirayama F; Koshio H; Matsumoto Y
    Eur J Pharmacol; 1998 Apr; 347(2-3):231-6. PubMed ID: 9653887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model.
    Deschênes I; Finkle CD; Winocour PD
    Thromb Haemost; 1998 Jul; 80(1):186-91. PubMed ID: 9684808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of human thrombin inhibition by two novel peptide inhibitors (Hirunorm IV and Hirunorm V).
    Cappiello M; Vilardo PG; Lippi A; Criscuoli M; Del Corso A; Mura U
    Biochem Pharmacol; 1996 Oct; 52(8):1141-6. PubMed ID: 8937420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of the specificity of dipetarudin by site directed mutagenesis.
    López M; Mende K; Nowak G
    Thromb Haemost; 2005 Mar; 93(3):430-6. PubMed ID: 15735791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of thrombin generation in plasma by inhibitors of factor Xa.
    Prasa D; Svendsen L; Stürzebecher J
    Thromb Haemost; 1997 Oct; 78(4):1215-20. PubMed ID: 9364987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational design of true hirudin mimetics: synthesis and characterization of multisite-directed alpha-thrombin inhibitors.
    Lombardi A; Nastri F; Della Morte R; Rossi A; De Rosa A; Staiano N; Pedone C; Pavone V
    J Med Chem; 1996 May; 39(10):2008-17. PubMed ID: 8642559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of thrombus growth by antithrombin III-dependent and two direct thrombin inhibitors in rabbits: implications for antithrombotic therapy.
    Brill-Edwards P; Van Ryn-McKenna J; Cai L; Ofosu FA; Buchanan MR
    Thromb Haemost; 1992 Oct; 68(4):424-7. PubMed ID: 1448774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin.
    Meyer BJ; Badimon JJ; Chesebro JH; Fallon JT; Fuster V; Badimon L
    Circulation; 1998 Feb; 97(7):681-5. PubMed ID: 9495304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
    Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.